|
|
| Line 1: |
Line 1: |
| [[Image:2flg.gif|left|200px]] | | {{Seed}} |
| | [[Image:2flg.png|left|200px]] |
|
| |
|
| <!-- | | <!-- |
| Line 9: |
Line 10: |
| {{STRUCTURE_2flg| PDB=2flg | SCENE= }} | | {{STRUCTURE_2flg| PDB=2flg | SCENE= }} |
|
| |
|
| '''Solution structure of an EGF-LIKE domain from the Plasmodium falciparum merozoite surface protein 1'''
| | ===Solution structure of an EGF-LIKE domain from the Plasmodium falciparum merozoite surface protein 1=== |
|
| |
|
|
| |
|
| ==Overview==
| | <!-- |
| The Plasmodium falciparum merozoite surface protein-1 19 kDa fragment (MSP-1(19)) comprises two closely packed EGF-like domains (EGF=epidermal growth factor), each stabilized by three disulfide bonds. The native conformation of this protein is important for eliciting P. falciparum growth inhibitory antibodies. Here we show that the N-terminal EGF domain alone can be chemically synthesized and efficiently refolded to a native-like state, as shown by its solution structure as determined by NMR spectroscopy. In order to study its immunogenicity, the domain was coupled through its N terminus to a phospholipid and incorporated into reconstituted influenza virus-like particles (virosomes). When used to immunize mice, the peptide-loaded virosomes elicited potent humoral immune responses that were shown by Western blots and immunofluorescence assays to cross-react with native MSP-1 on the surfaces of P. falciparum blood stage parasites. This opens the way for a medicinal chemistry-oriented approach to the study and optimization of the antigenicity of the protein as a potential malaria vaccine candidate, whilst exploiting the immunopotentiating properties of influenza virosomes as a delivery vehicle.
| | The line below this paragraph, {{ABSTRACT_PUBMED_17068840}}, adds the Publication Abstract to the page |
| | (as it appears on PubMed at http://www.pubmed.gov), where 17068840 is the PubMed ID number. |
| | --> |
| | {{ABSTRACT_PUBMED_17068840}} |
|
| |
|
| ==About this Structure== | | ==About this Structure== |
| 2FLG is a [[Single protein]] structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2FLG OCA]. | | 2FLG is a [[Single protein]] structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2FLG OCA]. |
|
| |
|
| ==Reference== | | ==Reference== |
| Line 31: |
Line 35: |
| [[Category: Surface antigen]] | | [[Category: Surface antigen]] |
| [[Category: Surface protein]] | | [[Category: Surface protein]] |
| ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 04:01:51 2008'' | | |
| | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 13:09:21 2008'' |